Abstract
Preclinical studies have implicated noradrenergic (NA) dysfunction in cocaine addiction. In particular, the NA system plays a central role in motivated behavior and may partake in the regulation of craving and drug use. Yet, human studies of the NA system are scarce, likely hampered by the difficulty in precisely localizing the locus coeruleus (LC). Here, we used neuromelanin imaging to localize the LC and quantified LC neuromelanin signal (NMS) intensity in 44 current cocaine users (CU; 37 men) and 59 nondrug users (NU; 44 men). We also employed fMRI to investigate cue-induced regional responses and LC functional connectivities, as quantified by generalized psychophysiological interaction (gPPI), in CU. Imaging data were processed by published routines and the findings were evaluated with a corrected threshold. We examined how these neural measures were associated with chronic cocaine craving, as assessed by the Cocaine Craving Questionnaire (CCQ). Compared to NU, CU demonstrated higher LC NMS for all probabilistic thresholds defined of 50–90% of the peak. In contrast, NMS of the ventral tegmental area/substantia nigra (VTA/SN) did not show significant group differences. Drug as compared to neutral cues elicited higher activations of many cortical and subcortical regions, none of which were significantly correlated with CCQ score. Drug vs. neutral cues also elicited “deactivation” of bilateral parahippocampal gyri (PHG) and PHG gPPI with a wide array of cortical and subcortical regions, including the ventral striatum and, with small volume correction, the LC. Less deactivation of the PHG (r = 0.40, p = 0.008) and higher PHG-LC gPPI (r = 0.44, p = 0.003) were positively correlated with the CCQ score. In contrast, PHG-VTA/SN connectivity did not correlate with the CCQ score. Together, chronic cocaine exposure may induce higher NMS intensity, suggesting neurotoxic effects on the LC. The correlation of cue-elicited PHG LC connectivity with CCQ score suggests a noradrenergic correlate of chronic cocaine craving. Potentially compensating for memory functions as in neurodegenerative conditions, cue-elicited PHG LC circuit connectivity plays an ill-adaptive role in supporting cocaine craving.
Subject terms: Predictive markers, Motivation
Introduction
Noradrenergic dysfunction in cocaine addiction
Although not as thoroughly investigated as dopamine (DA), norepinephrine (NE) has consistently been implicated in cocaine misuse [1–5]. For instance, in squirrel monkeys trained to stability and then extinguished for self-administration of cocaine, priming with NE transporter (NET) inhibitors reinstates drug seeking [3, 5]. In rodents too, noradrenergic (NA) agents have a robust effect on the reinstatement of stimulant seeking [5]. In humans NET genetic polymorphism modulates subjective mood responses to d-amphetamine in healthy individuals [6]. The polymorphisms are located at the transcription factor binding sites and thus likely to regulate the expression of NET gene. Relatively little is known about the effects of prolonged stimulant use on NA neurotransmission. Postmortem and animal studies have provided evidence in support of upregulation of NET after chronic cocaine exposure [7–9]. A more recent in-vivo study similarly demonstrated that NET is upregulated in humans addicted to cocaine [10]. Together, both clinical and preclinical studies support the role of NA signaling in the shaping and maintenance of cocaine addiction.
Locus coeruleus, motivated behavior, and drug craving
Both DA and NA systems are involved in motivating goal-directed behavior [11–14]. DA is best known for signaling unexpected and predicting upcoming reward [15]. More recent research has explored the role of DA in signaling aversive events [16, 17], broadening the scope of DA responses to saliency. Research of the NA system, on the other hand, has focused on its function in supporting arousal, attention, and stress-related behavior [18–21]. In particular, studies have accumulated to suggest the contribution of the NA circuits to effort and motivated behavior [22]. For instance, administration of clonidine, an α-2 NE receptor agonist that reduces central NE levels, decreased choice variability and force production in monkeys engaged in a sequential cost/benefit decision task [23]. Stimulant abuse may compromise the arousal-promoting function of the NA circuits and lead to dysmotivation syndrome [24]. In monkeys performing a task that involved reward/effort trade-off, NA neurons of the locus coeruleus (LC) increased in activity with both pupil dilation and effort production during reward-seeking behavior [25], suggesting a specific role of the LC in energizing behavior to challenges [26]. It has been suggested that combining molecular and/or neuromelanin imaging and functional magnetic resonance imaging (fMRI) is central to understanding the catecholaminergic processes of motivated behaviors in health and illness [27].
Drug seeking reflects a motivated behavior, and individuals with heavier use tend to demonstrate higher craving and more compulsive drug seeking [28–30]. Many imaging studies have employed cue-reactivity paradigms to investigate the neural processes of craving [31–38] and how the neural processes predict drug use and treatment outcome [39–42]. Drug craving is associated with biased attention to drug-related stimuli and physiological arousal, as supported by the NA circuit, including the midbrain nucleus LC [18]. Electrophysiological recordings show that the LC neurons respond to approach behavior, as during timed go trials in a go/no-go task [43], and most vigorously to complex arousing stimuli such as a preferred food [44]. It is thus highly likely that regional responses to drug cues interact with the LC to support craving and drug use.
Neurotoxic effects of chronic cocaine exposure
Chronic use of stimulants is known to be associated with neurotoxicity, potentially by way of excitotoxicity, mitochondrial and endoplasmic reticulum dysfunction, oxidative stress, and neuroinflammation [45–47]. Many of these neurotoxic processes have also been implicated in neurodegenerative changes as in Parkinson’s and Alzheimer’s disease, with studies suggesting earliest manifestation in the NA system that can be quantified by neuromelanin imaging [48]. Neuromelanin is identified in monoamines-containing neurons and formed by polymerization of 4,5-dihydroxyindole monomers [49] via enzymatic processes that involve the monoamine oxidase [50]. Neuromelanin chelates metals and protects against oxidative stress [51, 52]. Importantly, the cellular stress is evident during aging in neurotypical populations, with the LC neuromelanin contrast increasing until the sixth decade of life, when the compensatory process starts to fall apart, and decreasing afterwards [53, 54]. Thus, NMS of the LC does not simply suggest neurotoxicity but also reflect a protective mechanism for functional compensation, as observed during healthy aging [45]. With transcranial sonography an earlier study demonstrated higher echogenicity of the substantia nigra in stimulant users, as compared to controls and cannabis users, suggesting iron accumulation and microglia activation [55]. However, no studies to date have directly investigated neuromelanin signals (NMS) of the monoaminergic nuclei in cocaine users.
The present study
Here, we employed neuromelanin imaging to localize the LC and quantify its signal intensity as well as fMRI to query whole-brain responses and how these regional activities interact with the LC during exposure to drug vs. neutral cues in cocaine users (CU). We hypothesized higher NMS in cocaine users as compared to nonusers and higher regional cue-elicited connectivity with the LC in correlation with chronic cocaine craving in CU.
Participants and methods
Subjects and assessments
All participants signed an informed consent according to a protocol approved by the Human Investigation Committee at Yale University. Forty-four current cocaine users (CU; mean ± SD: 46.5 ± 7.2 years of age; 7 women) and 59 nonusers (NU; 43.7 ± 9.8 years, 15 women) were recruited from the greater New Have area of Connecticut. CU met Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) criteria for cocaine dependence [56], and tested positive for cocaine in urine toxicology. All were required to be physically healthy with no major medical illnesses, other Axis I disorders (except nicotine use disorders), current use of prescription medications, or history of head injury or neurological illness. CU who reported current use of other illicit substances or tested positive for methamphetamine, opioids, marijuana, barbiturates, or benzodiazepines were not invited to participate. Participants stayed at a locked inpatient unit at the Connecticut Mental Health Center and participated in the MR scan in 1–2 weeks. Participants were evaluated with the Cocaine Craving Questionnaire [57], Alcohol Use Disorders Identification Test [58], and the Fagerström Test for Nicotine Dependence [59]. Table 1 summarizes the demographic and clinical characteristics of the participants.
Table 1.
CU (n = 44) | NU (n = 59) | t | p | |
---|---|---|---|---|
Age (years) | 46.5 ± 7.2 | 43.7 ± 9.8 | 1.251 | 0.214 |
Gender (M/F) | 37/7 | 44/15 | 1.358 | 0.244ª |
Years of cocaine use | 17.6 ± 9.9 | N/A | N/A | N/A |
Days of cocaine use, prior month | 19.2 ± 8.5 | N/A | N/A | N/A |
Total use (gm), prior month | 30 ± 39 | N/A | N/A | N/A |
CCQ score | 40.0 ± 16.2 | N/A | N/A | N/A |
AUDIT score | 4.8 ± 5.7 | 3.7 ± 4.3 | 0.929 | 0.355 |
FTND score | 3.6 ± 2.8 | 0.3 ± 1.2 | 8.283 | <0.001 |
All values are mean ± S.D.
P values are based on independent-sample t test, except for gender compositiona (x2 test).
CCQ Cocaine Craving Questionnaire, AUDIT Alcohol Use Disorder Identification Test, FTND Fagerström Test for Nicotine Dependence.
Cue-reactivity task for fMRI
We employed a cue-reactivity task for fMRI as in a recent work [60]. Participants viewed cocaine-related or neutral pictures in alternating blocks. Briefly, a cross was used to engage attention at the beginning of each block. After 2 s, six pictures displaying cocaine-related cues (cocaine block) or neutral visual scenes (neutral block) were shown for 6 s each. Participants were asked to view the pictures and ponder how they might relate to the scenes. The pictures were collected from the internet and independently reviewed by two investigators. Cocaine pictures included individuals or a group of people using cocaine or images of cocaine. Neutral pictures comprised natural sceneries. Each block lasted about 45 s. A total of six cocaine and six neutral blocks took ~9 m to complete in each “run”. Each CU completed two runs of the task.
Imaging protocol and data preprocessing
Imaging data were obtained on a 3-Tesla Siemens Prisma scanner with multiband sequence. T1-weighted spin echo sagittal anatomical images were acquired for slice localization. A straight axial T1 FLASH structural image was obtained with TR = 440 ms, TE = 2.61 ms, bandwidth = 500 Hz/pixel, field of view = 220 × 220 mm, matrix = 256 × 256, 47 slices with 2.5 mm thickness and 1 mm gap. Four neuromelanin-sensitive-weighted MRI scans covering the LC and VTA/SNc were collected using a T1-weighted FSE sequence (straight axial, TR = 753 ms, TE = 12 ms, bandwidth = 222 Hz/pixel, flip angle = 120°, field of view = 220 × 220 mm, matrix = 512 × 512, 15 slices with 2.5 mm thickness and 1 mm gap, in-plane resolution = 0.429 × 0.429 mm2). The slices’ center was copied from the T1 FLASH image and moved down a number of slices, as adjusted for individual subjects to ensure LC coverage. This individual-specific number allowed us to insert the TSE scan to T1 FLASH template for normalization (see below). Anatomical 3D MPRAGE image were next obtained with spin echo imaging with TR = 2400 ms, TE = 1.18 ms, bandwidth = 610 Hz/pixel, field of view = 256 × 256 mm, matrix = 256 × 256, 208 slices at 1 mm and no gap. Functional, blood oxygen level-dependent (BOLD) signals were acquired with a single-shot gradient echo echoplanar imaging sequence. Seventy-five straight axial slices covering the whole brain were acquired with TR = 1000 ms, TE = 30 ms, bandwidth = 1894 Hz/pixel, flip angle = 55°, field of view = 220 × 220 mm, matrix = 110 × 110, 75 slices with 2 mm thickness and no gap.
We analyzed the imaging data with Statistical Parametric Mapping or SPM12. Because the FSE scan included only part of the brain, we used the resampled T1 FLASH image for normalization and applied the normalization parameters on the LC image. The T1 FLASH image was first resampled to match the in-plane resolution of the LC image (0.429 × 0.429 mm2). The 15 slices of the LC image were inserted into a 47-slice template in the same dimension with the resampled T1 FLASH image, generating a new LC image. In this way, the normalization parameters applied to resampled T1 FLASH image could be applied to the new LC image too. The MPRAGE image was co-registered with the resampled T1 FLASH image and then segmented for normalization with affine registration followed by nonlinear transformation [61–63]. The normalization parameters were then applied to the corresponding new LC images with a voxel size of 0.5 × 0.5 × 2 mm3.
In preprocessing of the BOLD signals, we aligned (motion-corrected) and corrected for slice timing of images of each individual subject, and constructed a mean functional image volume for each subject per run from the realigned volumes. We co-registered these mean images with the MPRAGE image and segmented the images for normalization with affine registration and nonlinear transformation. We applied the normalization parameters as determined for the structure volume to the corresponding functional images for each subject. The resampled voxel size was 3 × 3 × 3 mm3.
Controlling for physiological noise
The LC is adjacent to the fourth ventricle, and the BOLD signals in this region can potentially be affected by physiological noise. We used the DRIFTER SPM toolbox (http://becs.aalto.fi/en/research/bayes/drifter/) to remove the respiration and cardiac noises on the basis of a Bayesian model [64], as in our earlier work [65]. Briefly, the frequency trajectories of the physiological signals were first estimated by the interacting multiple models filter algorithm. The number of periodics to estimate was set as 1 to remove both respiration and cardiac noises. In a state-space model in combination of a Kalman filter and Rauch-Tung-Striebel smoother, BOLD time courses were separated into cleaned activation-related signal, physiological noise, and white noise.
Imaging data modeling
In modeling of the functional data, we distinguished cocaine and neutral cue blocks for each individual subject using a general linear model (GLM) that included the realignment parameters in all six dimensions. We corrected for serial autocorrelation caused by aliased cardiovascular and respiratory effects by a first-degree autoregressive model. We constructed for individual subjects a contrast of cocaine vs. neutral blocks to evaluate regional activities that differentiated viewing of cocaine and neutral pictures. The con (difference in β) images were used for group-level, random-effects analyses. In region of interest (ROI) analysis, we used MarsBaR (http://marsbar.sourceforge.net/) to derive for each individual subject the β contrast or “drug − neutral” activity for the ROIs. We showed all voxel activations in the Montreal Neurological Institute (MNI) coordinates and identified the brain regions by referring to an atlas [66].
Psychophysiological interaction (PPI)
We examined PPI with the LC during cue exposure (drug vs. neutral). PPI describes functional connectivity between brain regions contingent on a psychological context [67]. We used a generalized form of PPI (gPPI), where the inclusion of task regressors reduces the likelihood that the functional connectivity estimates are driven simply by co-activation [68]. The extracted mean time series of the BOLD signals were temporally filtered, mean corrected, and de-convolved to generate the time series of the neural signal for the LC mask for each individual subject to compose the physiological variable. These time series were then multiplied by the onset times of the blocks of interest separately, and re-convolved with the canonical HRF to obtain the interaction term or PPI variable. Finally, the blocks of interest, the physiological variable, and PPI variables were entered as regressors in a whole-brain GLM. GPPI analysis was performed for each individual subject, and the resulting contrast images were used in random-effects analyses. We tested specifically whether regional responses to drug (vs. neutral) cues interact with the LC and/or VTA/SNc, as defined by neuromelanin imaging (see below) and whether these gPPIs were correlated with CCQ scores.
Neuromelanin signal intensity
We computed for individual subjects the NMS of the LC and, as a contrast, the ventral tegmental area/substantia nigra, pars compacta (VTA/SNc), with the superior cerebellar peduncle (SCP) as a control region [69]: (LC − SCP)/(LC + SCP) and (VTA/SNc − SCP)/(VTA/SNc + SCP), respectively. We used a probabilistic template of the LC derived earlier [70] that represents the extent of peak LC signal distribution with a volume of 93 mm3. The template of the VTA/SNc was derived from structural MRIs [71] with a volume of 1106 mm3. We obtained the SCP template from the AAL atlas [72].
First, we verified for all subjects that the voxel with peak NMS lay within the LC and VTA/SNc template. Second, rather than computing the mean signal intensity of the masks, we considered voxels within an area that extended beyond the LC and VTA/SNc templates, considering that individual participants may vary in how LC and VTA/SNc voxels were distributed. This extended area comprised the voxels of the templates and three and one additional layers of voxels for the LC and VTA/SNc (797 and 2276 mm3), respectively. Finally, we computed each for the LC and VTA/SNc the average NMS for voxels with intensities exceeding a threshold each of 50–90% of the peak, using the afore-described formula. The masks of LC and VTA/SNc as identified served as the ROIs for gPPI analyses. Specifically, we tested the correlations of cue-elicited regional gPPI with the LC and VTA/SNc defined across multiple thresholds to ensure that the results were robust.
Results
Clinical assessments
As shown in Table 1, CU and NU did not differ in age, sex composition, or AUDIT score. CU showed significantly higher FTND score than NU. In all data analyses, we included age, sex, AUDIT and FTND scores as covariates. In CU, the CCQ score was positively correlated with days of cocaine use in the prior month (p = 0.010, r = 0.41) as well as total cocaine use in the prior month (p = 0.034, r = 0.34). In subsequent analyses, we focused on the CCQ score as an index of chronic craving, as in our previous studies [60, 73, 74].
Neuromelanin imaging of the LC and VTA/SNc
Relative to NU, CU showed higher NMS in the LC. Figure 1A shows the intensity values for different extents of the LC region, each covering voxels with ≥50–90% of the peak intensity. The NMS of the VTA/SNc did not show significant differences between CU and NU (Fig. 1B). The NMS of the LC was not correlated with years of cocaine use (r = 0.04, p = 0.788) or with the estimated life-time amount of cocaine use (r = 0.01, p = 0.969).
Cue-elicited regional activations in CU
Figure 2A shows the one-sample t test results of drug vs. neutral cues in CU. Bilateral lateral occipital, temporal, and fronto-parietal cortices, cerebellum, and medial frontal cortex showed higher activations to drug vs. neutral cues. Conversely, two clusters in bilateral parahippocampal gyrus (PHG) showed lower activations to drug vs. neutral cues. These clusters are summarized in Table 2.
Table 2.
Regions | Cluster | Voxel | MNI coordinates (mm) | ||
---|---|---|---|---|---|
Size (voxels) | Z value | X | Y | Z | |
Activation: drug > neutral cue* | |||||
L inferior occipital G | 905 | Inf | −42 | −76 | −2 |
R inferior temporal G | 634 | 7.45 | 45 | −61 | −8 |
R supramarginal G | 537 | 7.18 | 42 | −37 | 40 |
L superior parietal lobule | 788 | 7.18 | −39 | −46 | 55 |
Middle cingulate cortex | 88 | 6.38 | 3 | 2 | 31 |
L precentral G | 211 | 6.03 | −48 | 2 | 34 |
L cerebellum | 109 | 5.91 | −21 | −73 | −50 |
R cerebellum | 202 | 5.87 | 12 | −76 | −44 |
L superior frontal G | 173 | 5.73 | −18 | 47 | 43 |
R precentral G | 157 | 5.64 | 51 | 11 | 25 |
Ventromedial PFC | 58 | 5.61 | 0 | 35 | −23 |
L anterior insula | 30 | 5.47 | −36 | −4 | 7 |
L amygdala | 51 | 5.16 | −33 | −10 | −23 |
L thalamus | 12 | 5.04 | −3 | −31 | 4 |
L caudate | 24 | 4.99 | −27 | 35 | −14 |
Activation: drug < neutral cue | |||||
L parahippocampal G | 115 | −6.62 | −27 | −46 | −8 |
R parahippocampal G | 118 | −5.76 | 27 | −43 | −8 |
An asterisk indicates clusters surviving peak voxel p < 0.05 FWE corrected, with the cluster size shown for voxels meeting this threshold; L and R parahippocampal clusters also showed a peak voxel Z value that met voxel p < 0.05 FWE corrected; however, the cluster sizes are shown for voxel p < 0.001, uncorrected—thus, these clusters correspond exactly in size to those shown in Fig. 2A.
L left, R right, G gyrus, PFC prefrontal cortex.
We extracted the β contrasts (drug − neutral) of all identified clusters and observed with linear regressions that only bilateral PHG (left PHG, in particular) demonstrated cue-elicited activities (drug − neutral) in positive correlation with CCQ score, with age, sex, AUDIT and FTND scores as covariates (r = 0.38, p = 0.017, bilateral PHG; r = 0.46, p = 0.002, left PHG). That is, the PHG showed “deactivations” to drug vs. neutral cues and less deactivations were associated with higher chronic cocaine craving. None of the other clusters demonstrated cue activities in correlation with CCQ scores (all p’s > 0.141). The statistics of Pearson regressions are summarized in Table 3.
Table 3.
CCQ score | ||
---|---|---|
P | R | |
All positive clusters combined | 0.212 | 0.19 |
L inferior occipital/fusiform/inferior temporal G | 0.138 | 0.23 |
Supramarginal G/superior parietal lobule | 0.982 | 0.00 |
Superior parietal lobule/supramarginal G | 0.429 | 0.12 |
Superior frontal G | 0.253 | 0.18 |
Precentral/inferior frontal G | 0.826 | 0.03 |
All negative clusters combined | 0.008* | 0.40 |
L parahippocampal G | 0.002* | 0.46 |
R parahippocampal G | 0.053* | 0.30 |
Positive clusters: drug > neutral; negative clusters: neutral > drug.
L left, R right, G gyrus.
*p < 0.05.
Cue-elicited functional connectivity
Bilateral PHG showed cue-elicited activity in positive correlation with the CCQ score. Thus, we conducted a functional connectivity analysis to examine the generalized psychophysiological interaction (gPPI) of the bilateral PHG during exposure to drug vs. neutral cues in CU. We performed voxelwise analyses and the results of one-sample t test of gPPI are shown in Fig. 2B. The clusters meeting cluster threshold p < 0.05 FWE-corrected are summarized in Supplementary Table S1.
For individual clusters showing significant gPPI with bilateral PHG, we examined the correlation of the gPPI β values with the CCQ score and none showed a significant correlation (all p’s > 0.041, uncorrected).
To test our hypotheses of functional connectivity with midbrain nuclei, we computed the β contrast of gPPI for the LC mask (≥50% of peak NMS) and observed that bilateral PHG gPPI with the LC was significantly correlated with the CCQ score (r = 0.44, p = 0.003), with age, sex, AUDIT and FTND scores as covariates (Fig. 2B, lower left panel). The correlations were also significant for LC mask defined of 60% (p = 0.005), 70% (p = 0.026), and 80% (p = 0.035). For the mask defined of >90% intensity of the peak (comprising only 7.7 ± 9.6 mm3), the correlation was marginally significant (p = 0.058). Notably, with only the left PHG as seed, the findings remained similar: left PHG gPPI with the LC was significantly correlated with the CCQ score, with age, sex, AUDIT and FTND scores as covariates, for the LC mask defined of 50% (r = 0.37, p = 0.017), 60% (p = 0.022), and 70% (p = 0.049) intensity of the peak. In contrast, the gPPIs of the VTA/SNc as defined of 50% (p = 0.668, Fig. 2B, lower right panel), 60% (p = 0.687), 70% (p = 0.816), 80% (p = 0.586) and 90% (p = 0.397) of the peak intensity were not significantly correlated with the CCQ score. Thus, chronic cocaine craving was specifically associated with higher PHG gPPI with the LC.
Discussion
The current results are the first to show altered NMS intensity of the LC in CU. Further, with neuromelanin imaging to localize the LC in individual CU, we demonstrate cue-elicited LC functional connectivity in relation to chronic cocaine craving. These findings together provide evidence in humans for NA dysfunction in cocaine addiction. The VTA/SNc also showed higher NMS in CU than in NU, but the differences did not reach statistical significance. VTA/SNc connectivity with the PHG was not correlated with chronic cocaine craving. These findings together suggest an outsized impact of chronic cocaine exposure on the NA system and its more prominent role in supporting chronic cocaine craving.
Cocaine-induced neurotoxic effects on the LC
Previous investigations of the neurotoxic effects of stimulants, including cocaine, have focused on the dopaminergic system [46]. Here, we demonstrated significantly higher NMS in the LC in CU, as compared to NU, suggesting neurotoxic effects of cocaine on the NA system. As described earlier, the levels of NET are upregulated, indicating reduction of NA signaling, both in rhesus monkeys and humans chronically exposed to cocaine [8, 10]. A previous study reported a strong positive correlation between NMS intensity and NET levels in the LC of postmortem human brain [75]. Another study showed a significant inverse relationship between the number of remaining LC neurons and NE metabolism in the frontal cortex and LC, suggesting that remaining LC neurons are activated to compensate for decreased cerebral NE levels, in individuals with Alzheimer’s disease. This compensatory process, as reflected in LC connectivity with the hippocampus and PHG, may support memory functions in these neurodegenerative conditions [76–79].
Both in vivo and in vitro studies have reported that prenatal cocaine exposure inhibits neurite formation and induces LC neuronal damage and apoptosis [80, 81]. In an in-vitro study cocaine exposure preferentially induced LC cell apoptosis by disrupting membrane skeleton integrity and DNA repair, without significant effects on the survival of substantia nigra neurons [82]. In accord, we observed here significant higher LC but indistinguishable VTA/SNc NMS intensity in CU as compared to NU, suggesting that the LC neurons may be more vulnerable to cocaine exposure. On the other hand, this finding does not rule out neurotoxicity on dopaminergic neurons, which could potentially be demonstrated with a larger sample size. The findings together suggest that NMS intensity of the LC, as can be quantified by turbo-spin echo imaging, may represent a marker of the neurotoxic effects of cocaine on the NA system. On the other hand, it is noted that LC NMS intensity did not correlate with years of cocaine use or estimated life-time cocaine use in CU. It is possible that life-time cocaine consumption is difficult to quantify in chronic users, many with varying severity of cocaine use, including a hiatus in use, throughout their lifetime. The monoamingeric nuclei are vulnerable to other environmental toxicants, including pesticides and heavy metals. Further, as discussed earlier, the NMS does not simply suggest neurotoxicity but also reflect a neural protective mechanism.
Cue-related regional responses in cocaine users
Drug as compared to neutral cues evoked higher activations in the medial prefrontal cortex, amygdala, and fronto-parietal regions, as also reported in prior studies [31–36, 38]. In contrast, bilateral PHG showed lower activation in response to drug vs. neutral cues in CU. Although not typically implicated in cue-reactivity studies in cocaine using populations, an earlier work showed that smoking as compared to neutral cues evoked “deactivation” of bilateral PHG in smokers relative to non-smokers [83]. The PHG appeared to show higher cue-elicited activation in link with the severity of dependence in drug users [84–87]. Diminished cue-related PHG activation was associated with better treatment retention in CU [88], whereas higher activity was associated with relapse in smokers undergoing cessation treatment [85]. In heroin users the PHG showed higher cue-reactivity [89], and methadone maintenance treatment reduced PHG cue response [90]. Thus, the finding of less cue-induced “deactivation” of the PHG in association with chronic cocaine craving is consistent with this literature. These findings also suggest the complexity of cue-elicited responses [86] and the importance in considering inter-subject variation in drug use variables and abstinence status to fully evaluate cue reactivity.
LC functional connectivity in response to drug cues in cocaine users
Cue exposure frequently precedes drug seeking and consumption. Here, using a cue-reactivity paradigm, we demonstrated that both cue-elicited PHG activity and PHG-LC connectivity relate to chronic cocaine craving. Made possible by precisely localizing the LC with neuromelanin imaging, these findings provide direct evidence implicating the NA system in cocaine misuse. LC and PHG interaction may contribute to the retrieval of episodic memory [65, 78, 91–94] in relation to drug use. Earlier studies showed increased hippocampal and parahippocampal cue reactivities in relapsors vs. non-relapsors and as a predictor of relapse in drug users [95–97]. Consistent with this literature, the positive correlation of both cue-elicited PHG activity (less “deactivation”) and PHG-LC connectivity with craving supports the role of the NA circuit in the activation of drug-associated memory. Decreased suppression of the PHG may result in overall excitatory effects on the circuits of memory, interoception, reward/salience, and motivational drive [98] and contributes to drug use. Indeed, on the basis of causal modeling of the drug-cue processing neural network in cocaine users, an earlier study suggested a hippocampus→parahippocampal gyrus→orbital frontal cortex→ventral striatum pathway that associated reward/motivational processing with chronic cocaine use [99].
Limitations of the study and conclusions
A number of issues need to be considered. First, LC connectivities support chronic cocaine craving by engaging the PHG memory system. Untoward in the context of cue exposures, this circuit may also be involved in adaptive processes central to a healthy cognition. A study combining both cue-reactivity and nondrug-related memory tasks will show how PHG LC circuit is involved in memory encoding and retrieval in CU. Second, LC is a small structure, and, although the great majority of neuromelanin images were acquired with 3-Tesla machines, there has been discussion whether a 7-Telsa magnet demonstrates higher sensitivity. A recent work concluded that, while there is insufficient evidence to prefer the 7-T SPIR sequence over the 3 T TSE sequence, the isotropic voxels at 7 T confer an advantage in visualizing the LC [100]. Third, as discussed earlier, LC NMS increases to a peak around 60 years of age and starts to decline afterwards [101], along with deterioration in functional compensation for the age-related changes. It remains to be seen whether aging of the LC circuits, including the connectivity with the PHG, may account for diminution in drug craving in CU [102].
In conclusion, we demonstrate for the first time the effects of cocaine misuse on LC NMS and LC circuit response during cue exposure. The findings suggest a critical role of the NA system in supporting craving and may facilitate more research of NA dysfunction in cocaine addiction.
Funding and disclosure
Supported by NIH grants DA044749, DA023248, DA040032, and DA045743, as well as the Department of Mental Health and Addiction Services (DMHAS) of the State of Connecticut. The funding agencies otherwise have no roles in the conceptualization of the study, data collection and analysis, or the decision to publish these results. The authors declare no competing interests.
Supplementary information
Acknowledgements
We thank the medical and nursing staff at the Clinical Neuroscience Research Unit, Connecticut Mental Health Center for their medical care of the participants.
Author contributions
WW, SZh, and CRL contributed to the design of the experiments, WW and SZ contributed to data collection, WW, SZh, and SZ contributed to data analyses, and all authors contributed to the writing of the manuscript.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information accompanies this paper at (10.1038/s41386-020-00937-9).
References
- 1.Freeman KB, Rice KC, Riley AL. Assessment of monoamine transporter inhibition in the mediation of cocaine-induced conditioned taste aversion. Pharm Biochem Behav. 2005;82:583–9. doi: 10.1016/j.pbb.2005.10.014. [DOI] [PubMed] [Google Scholar]
- 2.Freeman KB, Verendeev A, Riley AL. Noradrenergic antagonism enhances the conditioned aversive effects of cocaine. Pharm Biochem Behav. 2008;88:523–32. doi: 10.1016/j.pbb.2007.10.011. [DOI] [PubMed] [Google Scholar]
- 3.Platt DM, Rowlett JK, Spealman RD. Noradrenergic mechanisms in cocaine-induced reinstatement of drug seeking in squirrel monkeys. J Pharm Exp Ther. 2007;322:894–902. doi: 10.1124/jpet.107.121806. [DOI] [PubMed] [Google Scholar]
- 4.Ventura R, Morrone C, Puglisi-Allegra S. Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Proc Natl Acad Sci USA. 2007;104:5181–6. doi: 10.1073/pnas.0610178104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Weinshenker D, Schroeder JP. There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology. 2007;32:1433–51. doi: 10.1038/sj.npp.1301263. [DOI] [PubMed] [Google Scholar]
- 6.Dlugos A, Freitag C, Hohoff C, McDonald J, Cook EH, Deckert J, et al. Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry. 2007;61:1296–305. doi: 10.1016/j.biopsych.2006.09.031. [DOI] [PubMed] [Google Scholar]
- 7.Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry. 2006;60:1111–20. doi: 10.1016/j.biopsych.2006.04.022. [DOI] [PubMed] [Google Scholar]
- 8.Macey DJ, Smith HR, Nader MA, Porrino LJ. Chronic cocaine self-administration upregulates the norepinephrine transporter and alters functional activity in the bed nucleus of the stria terminalis of the rhesus monkey. J Neurosci. 2003;23:12–6. doi: 10.1523/JNEUROSCI.23-01-00012.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S. Dopamine transport function is elevated in cocaine users. J Neurochem. 2002;81:292–300. doi: 10.1046/j.1471-4159.2002.00820.x. [DOI] [PubMed] [Google Scholar]
- 10.Ding YS, Singhal T, Planeta-Wilson B, Gallezot JD, Nabulsi N, Labaree D, et al. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT. Synapse. 2010;64:30–8. doi: 10.1002/syn.20696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Berridge CW, Arnsten AF. Psychostimulants and motivated behavior: arousal and cognition. Neurosci Biobehav Rev. 2013;37:1976–84. doi: 10.1016/j.neubiorev.2012.11.005. [DOI] [PubMed] [Google Scholar]
- 12.Castrellon JJ, Seaman KL, Crawford JL, Young JS, Smith CT, Dang LC, et al. Individual differences in dopamine are associated with reward discounting in clinical groups but not in healthy adults. J Neurosci. 2019;39:321–32. doi: 10.1523/JNEUROSCI.1984-18.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Salamone JD, Correa M, Ferrigno S, Yang JH, Rotolo RA, Presby RE. The psychopharmacology of effort-related decision making: dopamine, adenosine, and insights into the neurochemistry of motivation. Pharm Rev. 2018;70:747–62. doi: 10.1124/pr.117.015107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Watabe-Uchida M, Uchida N. Multiple dopamine systems: weal and woe of dopamine. Cold Spring Harb Symp Quant Biol. 2018;83:83–95. doi: 10.1101/sqb.2018.83.037648. [DOI] [PubMed] [Google Scholar]
- 15.Schultz W. Neuronal reward and decision signals: from theories to data. Physiol Rev. 2015;95:853–951. doi: 10.1152/physrev.00023.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gentry RN, Schuweiler DR, Roesch MR. Dopamine signals related to appetitive and aversive events in paradigms that manipulate reward and avoidability. Brain Res. 2019;1713:80–90. doi: 10.1016/j.brainres.2018.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Weele CMV, Siciliano CA, Tye KM. Dopamine tunes prefrontal outputs to orchestrate aversive processing. Brain Res. 2019;1713:16–31. doi: 10.1016/j.brainres.2018.11.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Aston-Jones G, Waterhouse B. Locus coeruleus: from global projection system to adaptive regulation of behavior. Brain Res. 2016;1645:75–8. doi: 10.1016/j.brainres.2016.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Borodovitsyna O, Flamini M, Chandler D. Noradrenergic modulation of cognition in health and disease. Neural Plast. 2017;2017:6031478. doi: 10.1155/2017/6031478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Borsook D, Linnman C, Faria V, Strassman AM, Becerra L, Elman I. Reward deficiency and anti-reward in pain chronification. Neurosci Biobehav Rev. 2016;68:282–97. doi: 10.1016/j.neubiorev.2016.05.033. [DOI] [PubMed] [Google Scholar]
- 21.Flavin SA, Winder DG. Noradrenergic control of the bed nucleus of the stria terminalis in stress and reward. Neuropharmacology. 2013;70:324–30. doi: 10.1016/j.neuropharm.2013.02.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Li GY, Ueki H, Kawashima T, Sugataka K, Muraoka T, Yamada S. Involvement of the noradrenergic system in performance on a continuous task requiring effortful attention. Neuropsychobiology. 2004;50:336–40. doi: 10.1159/000080962. [DOI] [PubMed] [Google Scholar]
- 23.Jahn CI, Gilardeau S, Varazzani C, Blain B, Sallet J, Walton ME, et al. Dual contributions of noradrenaline to behavioural flexibility and motivation. Psychopharmacology. 2018;235:2687–702. doi: 10.1007/s00213-018-4963-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.España RA, Schmeichel BE, Berridge CW. Norepinephrine at the nexus of arousal, motivation and relapse. Brain Res. 2016;1641:207–16. doi: 10.1016/j.brainres.2016.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Varazzani C, San-Galli A, Gilardeau S, Bouret S. Noradrenaline and dopamine neurons in the reward/effort trade-off: a direct electrophysiological comparison in behaving monkeys. J Neurosci. 2015;35:7866–77. doi: 10.1523/JNEUROSCI.0454-15.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ang YS, Manohar S, Apps MA. Commentary: noradrenaline and dopamine neurons in the reward/effort trade-off: a direct electrophysiological comparison in behaving monkeys. Front Behav Neurosci. 2015;9:310. doi: 10.3389/fnbeh.2015.00310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Berry AS, Jagust WJ, Hsu M. Age-related variability in decision-making: Insights from neurochemistry. Cogn Affect Behav Neurosci. 2019;19:415–34. doi: 10.3758/s13415-018-00678-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ahmed SH, Koob GF. Transition from moderate to excessive drug intake: change in hedonic set point. Science. 1998;282:298–300. doi: 10.1126/science.282.5387.298. [DOI] [PubMed] [Google Scholar]
- 29.Lüscher C, Robbins TW, Everitt BJ. The transition to compulsion in addiction. Nat Rev Neurosci. 2020;21:247–63. doi: 10.1038/s41583-020-0289-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Smith RJ, Laiks LS. Behavioral and neural mechanisms underlying habitual and compulsive drug seeking. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87:11–21. doi: 10.1016/j.pnpbp.2017.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bonson KR, Grant SJ, Contoreggi CS, Links JM, Metcalfe J, Weyl HL, et al. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology. 2002;26:376–86. doi: 10.1016/S0893-133X(01)00371-2. [DOI] [PubMed] [Google Scholar]
- 32.Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O’Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry. 1999;156:11–8. doi: 10.1176/ajp.156.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, et al. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry. 2000;157:1789–98. doi: 10.1176/appi.ajp.157.11.1789. [DOI] [PubMed] [Google Scholar]
- 34.Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C, et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA. 1996;93:12040. [DOI] [PMC free article] [PubMed]
- 35.Kilts CD, Schweitzer JB, Quinn CK, Gross RE, Faber TL, Muhammad F, et al. Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry. 2001;58:334–41. doi: 10.1001/archpsyc.58.4.334. [DOI] [PubMed] [Google Scholar]
- 36.Potenza MN, Hong K-IA, Lacadie CM, Fulbright RK, Tuit KL, Sinha R. Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence. Am J Psychiatry. 2012;169:406–14. doi: 10.1176/appi.ajp.2011.11020289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Sinha R, Lacadie C, Skudlarski P, Fulbright RK, Rounsaville BJ, Kosten TR, et al. Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology. 2005;183:171–80. doi: 10.1007/s00213-005-0147-8. [DOI] [PubMed] [Google Scholar]
- 38.Wilcox CE, Teshiba TM, Merideth F, Ling J, Mayer AR. Enhanced cue reactivity and fronto-striatal functional connectivity in cocaine use disorders. Drug Alcohol Depend. 2011;115:137–44. doi: 10.1016/j.drugalcdep.2011.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Paulus MP, Tapert SF, Schuckit MA. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry. 2005;62:761–8. doi: 10.1001/archpsyc.62.7.761. [DOI] [PubMed] [Google Scholar]
- 40.Sebold M, Nebe S, Garbusow M, Guggenmos M, Schad DJ, Beck A, et al. When HAbits Are Dangerous: Alcohol Expectancies and Habitual Decision Making Predict Relapse in Alcohol Dependence. Biol Psychiatry. 2017;82:847–56. doi: 10.1016/j.biopsych.2017.04.019. [DOI] [PubMed] [Google Scholar]
- 41.Siciliano CA, Noamany H, Chang CJ, Brown AR, Chen X, Leible D, et al. A cortical-brainstem circuit predicts and governs compulsive alcohol drinking. Science. 2019;366:1008–12. doi: 10.1126/science.aay1186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Yip SW, Scheinost D, Potenza MN, Carroll KM. Connectome-based prediction of cocaine abstinence. Am J Psychiatry. 2019;176:156–64. doi: 10.1176/appi.ajp.2018.17101147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Moore RY, Bloom FE. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci. 1979;2:113–68. doi: 10.1146/annurev.ne.02.030179.000553. [DOI] [PubMed] [Google Scholar]
- 44.Foote SL, Aston-Jones G, Bloom FE. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl Acad Sci USA. 1980;77:3033–7. doi: 10.1073/pnas.77.5.3033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Clark KH, Wiley CA, Bradberry CW. Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection. Neurotox Res. 2013;23:174–88. doi: 10.1007/s12640-012-9334-7. [DOI] [PubMed] [Google Scholar]
- 46.Pereira RB, Andrade PB, Valentão P. A comprehensive view of the neurotoxicity mechanisms of cocaine and ethanol. Neurotox Res. 2015;28:253–67. doi: 10.1007/s12640-015-9536-x. [DOI] [PubMed] [Google Scholar]
- 47.Yamamoto BK, Moszczynska A, Gudelsky GA. Amphetamine toxicities classical and emerging mechanisms. Ann N. Y Acad Sci. 2010;1187:101. doi: 10.1111/j.1749-6632.2009.05141.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Peterson AC, Li CR. Noradrenergic dysfunction in Alzheimer’s and Parkinson’s diseases-an overview of imaging studies. Front Aging Neurosci. 2018;10:127. doi: 10.3389/fnagi.2018.00127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Charkoudian LK, Franz KJ. Fe (III)-coordination properties of neuromelanin components: 5, 6-dihydroxyindole and 5, 6-dihydroxyindole-2-carboxylic acid. Inorg Chem. 2006;45:3657–64. doi: 10.1021/ic060014r. [DOI] [PubMed] [Google Scholar]
- 50.Rabey J, Hefti F. Neuromelanin synthesis in rat and human substantia nigra. J Neural Transm-Parkinson’s Dis Dement Sect. 1990;2:1–14. doi: 10.1007/BF02251241. [DOI] [PubMed] [Google Scholar]
- 51.Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson’s disease. Neuroreport. 2006;17:1215–8. doi: 10.1097/01.wnr.0000227984.84927.a7. [DOI] [PubMed] [Google Scholar]
- 52.Tribl F, Asan E, Arzberger T, Tatschner T, Langenfeld E, Meyer HE, et al. Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach. Mol Cell Proteomics. 2009;8:1832–8. doi: 10.1074/mcp.M900006-MCP200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Clewett DV, Lee T-H, Greening S, Ponzio A, Margalit E, Mather M. Neuromelanin marks the spot: identifying a locus coeruleus biomarker of cognitive reserve in healthy aging. Neurobiol Aging. 2016;37:117–26. doi: 10.1016/j.neurobiolaging.2015.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Shibata E, Sasaki M, Tohyama K, Kanbara Y, Otsuka K, Ehara S, et al. Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. Magn Reson Med Sci. 2006;5:197–200. doi: 10.2463/mrms.5.197. [DOI] [PubMed] [Google Scholar]
- 55.Todd G, Noyes C, Flavel SC, Della Vedova CB, Spyropoulos P, Chatterton B, et al. Illicit stimulant use is associated with abnormal substantia nigra morphology in humans. PloS one. 2013;8:e56438. doi: 10.1371/journal.pone.0056438. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.First MSR, Williams J, Gibbon M. Structured Clinical Interview for DSM-IV (SCID) Washington DC: American Psychiatric Association; 1995. [Google Scholar]
- 57.Tiffany ST, Singleton E, Haertzen CA, Henningfield JE. The development of a cocaine craving questionnaire. Drug Alcohol Depend. 1993;34:19–28. doi: 10.1016/0376-8716(93)90042-o. [DOI] [PubMed] [Google Scholar]
- 58.Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The alcohol use disorders identification test. Geneva: World Health Organization, Department of Mental Health and Substance Dependence; 2001. [Google Scholar]
- 59.Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119–27. doi: 10.1111/j.1360-0443.1991.tb01879.x. [DOI] [PubMed] [Google Scholar]
- 60.Zhang S, Zhornitsky S, Le TM, Li CR. Hypothalamic responses to cocaine and food cues in individuals with cocaine dependence. Int J Neuropsychopharmacol. 2019;22:754–64. doi: 10.1093/ijnp/pyz044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp. 1999;7:254–66. doi: 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Friston K, Ashburner J, Frith C, Polone J, Heather J, Frackowiak R. Spatial registration and normalization of images. Hum Brain Mapp. 1995;2:165–89. [Google Scholar]
- 63.Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RS. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp. 1994;2:189–210. [Google Scholar]
- 64.Särkkä S, Solin A, Nummenmaa A, Vehtari A, Auranen T, Vanni S, et al. Dynamic retrospective filtering of physiological noise in BOLD fMRI: DRIFTER. Neuroimage. 2012;60:1517–27. doi: 10.1016/j.neuroimage.2012.01.067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Zhang S, Hu S, Chao HH, Li CS. Resting-state functional connectivity of the locus coeruleus in humans: in comparison with the ventral tegmental area/substantia nigra pars compacta and the effects of age. Cereb Cortex. 2016;26:3413–27. doi: 10.1093/cercor/bhv172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Duvornoy H. The human brain. Surface, three-dimensional sectional anatomy with MRI, and blood supply. New York, NY: Springer-Verlag Wein; 1999. [Google Scholar]
- 67.Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan RJ. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage. 1997;6:218–29. doi: 10.1006/nimg.1997.0291. [DOI] [PubMed] [Google Scholar]
- 68.McLaren DG, Ries ML, Xu G, Johnson SC. A generalized form of context-dependent psychophysiological interactions (gPPI): a comparison to standard approaches. Neuroimage. 2012;61:1277–86. doi: 10.1016/j.neuroimage.2012.03.068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Ogisu K, Kudo K, Sasaki M, Sakushima K, Yabe I, Sasaki H, et al. 3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s disease. Neuroradiology. 2013;55:719–24. doi: 10.1007/s00234-013-1171-8. [DOI] [PubMed] [Google Scholar]
- 70.Keren NI, Lozar CT, Harris KC, Morgan PS, Eckert MA. In vivo mapping of the human locus coeruleus. Neuroimage. 2009;47:1261–7. doi: 10.1016/j.neuroimage.2009.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Ahsan RL, Allom R, Gousias IS, Habib H, Turkheimer FE, Free S, et al. Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus. Neuroimage. 2007;38:261–70. doi: 10.1016/j.neuroimage.2007.06.004. [DOI] [PubMed] [Google Scholar]
- 72.Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273–89. doi: 10.1006/nimg.2001.0978. [DOI] [PubMed] [Google Scholar]
- 73.Zhang S, Wang W, Zhornitsky S, Li CR. Resting state functional connectivity of the lateral and medial hypothalamus in cocaine dependence: an exploratory study. Front Psychiatry. 2018;9:344. doi: 10.3389/fpsyt.2018.00344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Zhang S, Zhornitsky S, Angarita GA, Li CR. Hypothalamic response to cocaine cues and cocaine addiction severity. Addict Biol. 2020;25:e12682. doi: 10.1111/adb.12682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Ordway GA, Stockmeier CA, Cason GW, Klimek V. Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J Neurosci. 1997;17:1710–9. doi: 10.1523/JNEUROSCI.17-05-01710.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev. 2003;42:33–84. doi: 10.1016/s0165-0173(03)00143-7. [DOI] [PubMed] [Google Scholar]
- 77.Hoogendijk WJG, Feenstra MGP, Botterblom MHA, Gilhuis J, Sommer IEC, Kamphorst W, et al. Increased activity of surviving locus ceruleus neurons in Alzheimer’s disease. Ann Neurol. 1999;45:82–91. doi: 10.1002/1531-8249(199901)45:1<82::aid-art14>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
- 78.Jacobs HI, Wiese S, van de Ven V, Gronenschild EH, Verhey FR, Matthews PM. Relevance of parahippocampal-locus coeruleus connectivity to memory in early dementia. Neurobiol Aging. 2015;36:618–26. doi: 10.1016/j.neurobiolaging.2014.10.041. [DOI] [PubMed] [Google Scholar]
- 79.Szot P, White SS, Lynne Greenup J, Leverenz JB, Peskind ER, Raskind MA. Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer’s disease and dementia with lewy bodies. J Neurosci. 2006;26:467–78. doi: 10.1523/JNEUROSCI.4265-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Dey S, Mactutus C, Booze R, Snow D. Specificity of prenatal cocaine on inhibition of locus coeruleus neurite outgrowth. Neuroscience. 2006;139:899–907. doi: 10.1016/j.neuroscience.2005.12.053. [DOI] [PubMed] [Google Scholar]
- 81.Snow DM, Smith J, Booze R, Welch M, Mactutus C. Cocaine decreases cell survival and inhibits neurite extension of rat locus coeruleus neurons. Neurotoxicology Teratol. 2001;23:225–34. doi: 10.1016/s0892-0362(01)00137-4. [DOI] [PubMed] [Google Scholar]
- 82.Dey S, Mactutus CF, Booze RM, Snow DM. Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons by altering the Bax/Bcl-2 ratio and through caspase-3 apoptotic signaling. Neuroscience. 2007;144:509–21. doi: 10.1016/j.neuroscience.2006.09.04. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Artiges E, Ricalens E, Berthoz S, Krebs MO, Penttilä J, Trichard C, et al. Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers. Addict Biol. 2009;14:469–77. doi: 10.1111/j.1369-1600.2009.00167.x. [DOI] [PubMed] [Google Scholar]
- 84.Claus ED, Ewing SW, Filbey FM, Sabbineni A, Hutchison KE. Identifying neurobiological phenotypes associated with alcohol use disorder severity. Neuropsychopharmacology. 2011;36:2086–96. doi: 10.1038/npp.2011.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Janes AC, Pizzagalli DA, Richardt S, de BFB, Chuzi S, Pachas G, et al. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry. 2010;67:722–9. doi: 10.1016/j.biopsych.2009.12.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Jasinska AJ, Stein EA, Kaiser J, Naumer MJ, Yalachkov Y. Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci Biobehav Rev. 2014;38:1–16. doi: 10.1016/j.neubiorev.2013.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Smolka MN, Bühler M, Klein S, Zimmermann U, Mann K, Heinz A, et al. Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery. Psychopharmacology. 2006;184:577–88. doi: 10.1007/s00213-005-0080-x. [DOI] [PubMed] [Google Scholar]
- 88.Jia Z, Worhunsky PD, Carroll KM, Rounsaville BJ, Stevens MC, Pearlson GD, et al. An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol Psychiatry. 2011;70:553–60. doi: 10.1016/j.biopsych.2011.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Hassani-Abharian P, Ganjgahi H, Tabatabaei-Jafari H, Oghabian MA, Mokri A, Ekhtiari H. Exploring neural correlates of different dimensions in drug craving self-reports among heroin dependents. Basic Clin Neurosci. 2015;6:271–84. [PMC free article] [PubMed] [Google Scholar]
- 90.Langleben DD, Ruparel K, Elman I, Busch-Winokur S, Pratiwadi R, Loughead J, et al. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry. 2008;165:390–4. doi: 10.1176/appi.ajp.2007.07010070. [DOI] [PubMed] [Google Scholar]
- 91.Eichenbaum H, Lipton PA. Towards a functional organization of the medial temporal lobe memory system: role of the parahippocampal and medial entorhinal cortical areas. Hippocampus. 2008;18:1314–24. doi: 10.1002/hipo.20500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Lemon N, Aydin-Abidin S, Funke K, Manahan-Vaughan D. Locus coeruleus activation facilitates memory encoding and induces hippocampal LTD that depends on beta-adrenergic receptor activation. Cerebral cortex. 2009;19:2827–37. [DOI] [PMC free article] [PubMed]
- 93.Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci. 2009;10:211–23. doi: 10.1038/nrn2573. [DOI] [PubMed] [Google Scholar]
- 94.Sara SJ, Bouret S. Orienting and reorienting: the locus coeruleus mediates cognition through arousal. Neuron. 2012;76:130–41. doi: 10.1016/j.neuron.2012.09.011. [DOI] [PubMed] [Google Scholar]
- 95.Adinoff B, Gu H, Merrick C, McHugh M, Jeon-Slaughter H, Lu H, et al. Basal hippocampal activity and its functional connectivity predicts cocaine relapse. Biol Psychiatry. 2015;78:496–504. doi: 10.1016/j.biopsych.2014.12.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Castilla-Ortega E, Serrano A, Blanco E, Araos P, Suárez J, Pavón FJ, et al. A place for the hippocampus in the cocaine addiction circuit: Potential roles for adult hippocampal neurogenesis. Neurosci Biobehav Rev. 2016;66:15–32. doi: 10.1016/j.neubiorev.2016.03.030. [DOI] [PubMed] [Google Scholar]
- 97.Mitchell MR, Balodis IM, DeVito EE, Lacadie CM, Yeston J, Scheinost D, et al. A preliminary investigation of Stroop-related intrinsic connectivity in cocaine dependence: associations with treatment outcomes. Am J Drug Alcohol Abus. 2013;39:392–402. doi: 10.3109/00952990.2013.841711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Moulton EA, Elman I, Becerra LR, Goldstein RZ, Borsook D. The cerebellum and addiction: insights gained from neuroimaging research. Addiction Biol. 2014;19:317–31. doi: 10.1111/adb.12101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Ray S, Haney M, Hanson C, Biswal B, Hanson SJ. Modeling causal relationship between brain regions within the drug-cue processing network in chronic cocaine smokers. Neuropsychopharmacology. 2015;40:2960–8. doi: 10.1038/npp.2015.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Tona K-D, van Osch MJP, Nieuwenhuis S, Keuken MC. Quantifying the contrast of the human locus coeruleus in vivo at 7 Tesla MRI. PloS one. 2019;14:e0209842. doi: 10.1371/journal.pone.0209842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Liu KY, Acosta-Cabronero J, Cardenas-Blanco A, Loane C, Berry AJ, Betts MJ, et al. In vivo visualization of age-related differences in the locus coeruleus. Neurobiol Aging. 2019;74:101–11. doi: 10.1016/j.neurobiolaging.2018.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Hintzen AK, Cramer J, Karagülle D, Heberlein A, Frieling H, Kornhuber J, et al. Does alcohol craving decrease with increasing age? Results from a cross-sectional study. J Stud Alcohol Drugs. 2011;72:158–62. doi: 10.15288/jsad.2011.72.158. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.